2篇
您的检索式：作者名="Gaoke Feng"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Peroxymonosulfate activation based on Co_(9)S_(8)@N-C:A new strategy for highly efficient hydrogen production and synchronous formaldehyde removal in wastewater显示文摘Formaldehyde(FA),as an important chemical raw material,has been widely used in many fields.However,the discharge of a large amount of FA-containing wastewater poses a serious threat to the environment and human health.Recently,the in-situ hydrogen energy release technology of hydrogen-containing stable liquid has been extensively explored due to its safe storage.Exploring a robust method to achieve FA removal and synchronous in-situ hydrogen release from FA containing wastewater is of great significant for environmental protection and energy crisis alleviation.Here,we have innovatively introduced peroxymonosulfate(PMS)activation technology into FA removal and hydrogen production simultaneously.The composite of nitrogen doped carbon coating Co_(9)S_(8)nanotubes(Co_(9)S_(8)@N-C)is employed as a proof of concept for FA decomposition and simultaneously hydrogen production based on PMS activation system.As expected,the Co_(9)S_(8)@N-C/PMS system presents much superior hydrogen production efficiency and satisfactory FA removal rate towards FA wastewater than those of common catalysis,photocatalysis and Fenton reaction in the basic condition in a wide range of FA concentration.The hydrogen yield reaches a value as high as 471μmol within 60 min,corresponding to a FA degradation rate of 30%with an initial FA concentration of 0.722 mol L^(-1).Characterizations and density functional theory(DFT)calculations suggest that the free radical process dominated by superoxide radical(O_(2)·^(-))and nonradical process dominated by singlet oxygen(^(1)O_(2)),which are induced by Co_(9)S_(8)@N-C/PMS system,are responsible for highly efficient hydrogen production via FA degradation.These generated O_(2)·^(-)and ^(1)O_(2)can extract·H from FA to form·OOH intermediate,which can further combine with the·H from water to produce hydrogen.This study provides an applicable technique for environmental purification and new energy development based on FA containing wastewater. | Caiyan Gao Xuezhen Feng Lian Yi Xiaoyong Wu Renji Zheng Gaoke Zhang Yubiao Li | 2022 | Journal of Materials Science & Technology2022，，32： | 0 |
| 2 | The lysine methyltransferase SMYD2 facilitates neointimal hyperplasia by regulating the HDAC3-SRF axis显示文摘Coronary restenosis is an important cause of poor long-term prognosis in patients with coronary heart disease.Here,we show that lysine methyltransferase SMYD2 expression in the nucleus is significantly elevated in serum-and PDGF-BB-induced vascular smooth muscle cells(VSMCs),and in tissues of carotid artery injury-induced neointimal hyperplasia.Smyd2 overexpression in VSMCs(Smyd2-vTg)facilitates,but treatment with its specific inhibitor LLY-507 or SMYD2 knockdown significantly inhibits VSMC phenotypic switching and carotid artery injury-induced neointima formation in mice.Transcriptome sequencing revealed that SMYD2 knockdown represses the expression of serum response factor(SRF)target genes and that SRF overexpression largely reverses the inhibitory effect of SMYD2 knockdown on VSMC proliferation.HDAC3 directly interacts with and deacetylates SRF,which enhances SRF transcriptional activity in VSMCs.Moreover,SMYD2 promotes HDAC3 expression via tri-methylation of H3K36 at its promoter.RGFP966,a specific inhibitor of HDAC3,not only counteracts the pro-proliferation effect of SMYD2 overexpression on VSMCs,but also inhibits carotid artery injury-induced neointima formation in mice.HDAC3 partially abolishes the inhibitory effect of SMYD2 knockdown on VSMC proliferation in a deacetylase activity-dependent manner.Our results reveal that the SMYD2-HDAC3-SRF axis constitutes a novel and critical epigenetic mechanism that regulates VSMC phenotypic switching and neointimal hyperplasia. | Xiaoxuan Zhong Xiang Wei Yan Xu Xuehai Zhu Bo Huo Xian Guo Gaoke Feng Zihao Zhang Xin Feng Zemin Fang Yuxuan Luo Xin Yi Ding-Sheng Jiang | 2024 | Acta Pharmaceutica Sinica B2024，14，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员